E. Winton

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · Haematologica · 2015 · 329 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Association of busulfan area under the curve with veno-occlusive disease following BMT.

S P Dix, John R. Wingard, Richard E. Mullins et al. · PubMed · 1996 · 323 citations

Medicine, Hematology, Hematopathology +3

Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · Haematologica · 2013 · 162 citations · Full text

Medicine, Hematology, Pharmacology +14

Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia

Kim-Hien T. Dao, Jason Gotlib, Michael M.N. Deininger et al. · Journal of Clinical Oncology · 2019 · 109 citations · Full text

Medicine, Oncology, Pharmacology +5

Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.

H. Kent Holland, S P Dix, Robert B. Geller et al. · Journal of Clinical Oncology · 1996 · 50 citations

Medicine, Oncology, Breast Oncology +16